BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2327344)

  • 1. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction.
    Queen M; Biem HJ; Moe GW; Sugar L
    Am J Cardiol; 1990 Apr; 65(15):1042-3. PubMed ID: 2327344
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol embolization after intravenous streptokinase therapy in acute myocardial infarction].
    Bucher A; Roald B
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1844-5. PubMed ID: 8322322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atheromatous material mobilization syndrome after thrombolytic therapy with streptokinase in acute myocardial infarct].
    Arpesani A; Beretta L; Giorgetti PL; Varesi C; Matturri L
    Minerva Cardioangiol; 1991 Jun; 39(6):251-4. PubMed ID: 1961445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol embolisation syndrome after thrombolytic therapy for myocardial infarction.
    Pochmalicki G; Feldman L; Meunier P; Rougeot C; Weschler J; Jan F
    Lancet; 1992 Jan; 339(8784):58-9. PubMed ID: 1345976
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction.
    Schwartz MW; McDonald GB
    JAMA; 1987 Oct; 258(14):1934-5. PubMed ID: 3656605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal adverse effects of streptokinase therapy.
    Birnbaum Y; Hasdai D; Stahl B
    Int J Cardiol; 1994 Aug; 46(1):1-6. PubMed ID: 7960270
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction.
    Wong FK; Chan SK; Ing TS; Li CS
    Am J Kidney Dis; 1995 Sep; 26(3):508-10. PubMed ID: 7645560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute anuric renal failure: a complication of combined thrombolytic and antithrombotic therapy.
    Toupin LR; Blanchard DG
    Int J Cardiol; 1993 Jul; 40(3):283-5. PubMed ID: 8225663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholesterol crystal emboli after fibrinolytic treatment].
    Dupin N; Chosidow O; Pochmaliki G; Assier H; Rethers L; Meunier P; Jan F; Roujeau JC
    Ann Dermatol Venereol; 1992; 119(11):842-4. PubMed ID: 1301696
    [No Abstract]   [Full Text] [Related]  

  • 13. [Syndrome of multiple cholesterol embolism after parenteral streptokinase therapy of acute myocardial infarct: description of an autopsy case].
    Matturri L; Varesi C; Rossi L
    Cardiologia; 1991 Jan; 36(1):59-61. PubMed ID: 1878901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptokinase-induced jaundice in patients with acute myocardial infarction.
    Mager A; Birnbaum Y; Zlotikamien B; Strasberg B; Rechavia E; Sagie A; Sclarovsky S
    Am Heart J; 1991 May; 121(5):1543-4. PubMed ID: 2017987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diffuse cholesterol embolism after fibrinolysis for myocardial infarction].
    Pochmalicki G; Meunier P; Feldman L; Rougeau JC; Chosidow O; Wechsler J; Jan F
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):263-6. PubMed ID: 8363430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator.
    Gupta BK; Spinowitz BS; Charytan C; Wahl SJ
    Am J Kidney Dis; 1993 Jun; 21(6):659-62. PubMed ID: 8503421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute coronary embolism complicating aortic valve endocarditis treated with streptokinase and aspirin. A case report.
    Connolly DL; Dardas PS; Crowley JJ; Kenny A; Petch MC
    J Heart Valve Dis; 1994 May; 3(3):245-6. PubMed ID: 8087259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteinuria with streptokinase.
    Lynch M; Pentecost BL; Littler WA; Stockley RA
    Lancet; 1993 Apr; 341(8851):1024. PubMed ID: 8096904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.